---
ver: rpa2
title: 'RURA-Net: A general disease diagnosis method based on Zero-Shot Learning'
arxiv_id: '2503.00052'
source_url: https://arxiv.org/abs/2503.00052
tags:
- disease
- learning
- network
- accuracy
- clustering
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: 'This paper presents RURA-Net, a Zero-Shot Learning (ZSL)-based
  framework for disease diagnosis that addresses the challenge of high annotation
  costs in medical imaging. The method combines three key components: a Siamese neural
  network to identify disease similarities, a U-Net segmentation model to isolate
  pathological features, and a ResNet-Agglomerative clustering algorithm for classification.'
---

# RURA-Net: A general disease diagnosis method based on Zero-Shot Learning

## Quick Facts
- arXiv ID: 2503.00052
- Source URL: https://arxiv.org/abs/2503.00052
- Reference count: 21
- Key outcome: Achieved accuracy=0.8395, precision=0.8094, recall=0.8463, F1 Score=0.8274, and AUC=0.9226 on ophthalmic disease diagnosis

## Executive Summary
This paper presents RURA-Net, a Zero-Shot Learning (ZSL)-based framework for disease diagnosis that addresses the challenge of high annotation costs in medical imaging. The method combines three key components: a Siamese neural network to identify disease similarities, a U-Net segmentation model to isolate pathological features, and a ResNet-Agglomerative clustering algorithm for classification. Evaluated on ophthalmic disease datasets, RURA-Net achieved strong performance metrics while demonstrating robustness to data scarcity. The approach represents a significant advancement in ZSL for medical diagnosis where labeled data is scarce.

## Method Summary
RURA-Net is a three-stage pipeline for Zero-Shot Learning disease diagnosis. First, a Siamese neural network (VGG19 backbone) identifies a similar disease with abundant labeled data as a proxy for the target disease. Second, a U-Net segmentation model (ResNet50 backbone) isolates key pathological features (lesions) from the proxy disease images. Third, a ResNet18 feature extractor processes the segmented images, and an Agglomerative Clustering algorithm groups samples to diagnose the target disease without requiring any labeled examples of it. The method was validated on ophthalmic datasets including LCFP-14M, MESSIDOR, MAPLES-DR, and Eyepacs.

## Key Results
- Achieved accuracy=0.8395, precision=0.8094, recall=0.8463, F1 Score=0.8274, and AUC=0.9226 on ophthalmic disease diagnosis
- Outperformed most Few-Shot and One-Shot Learning baselines in comparative analysis
- Ablation studies confirmed necessity of both disease similarity analysis and lesion segmentation steps
- U-Net segmentation was critical: accuracy dropped from 0.8395 to 0.3074 when segmentation was removed

## Why This Works (Mechanism)

### Mechanism 1: Proxy Domain Selection via Siamese Similarity
The model circumvents absence of labeled target data by identifying a "surrogate" disease with abundant labels that shares visual or pathological features with the target. A Siamese Neural Network (VGG19 backbone) compares feature maps of known diseases to the target disease concept using L1 norm distance and Contrastive Loss to output a similarity score. The disease with highest similarity (e.g., Degenerative Myopia as proxy for Mild Diabetic Retinopathy) provides the training data distribution.

### Mechanism 2: Signal-to-Noise Isolation via Lesion Segmentation
Diagnostic accuracy is preserved during domain transfer by restricting feature space to clinically relevant lesion masks rather than whole images. A U-Net (ResNet50 backbone) segments specific lesion types (Microaneurysms, Hemorrhages) based on clinical definitions of the target disease. By masking input images, the model removes background artifacts before clustering phase, ensuring clustering algorithm groups data based on pathology rather than imaging artifacts.

### Mechanism 3: Unsupervised Boundary Formation via Agglomerative Clustering
The system achieves "Zero-Shot" classification by projecting features into space where decision boundaries emerge from data density rather than gradient descent on labels. Features extracted by ResNet18 are processed using Agglomerative Clustering (AGG), which builds hierarchy of merges based on distance metrics, allowing model to separate diseased from non-diseased states based on intrinsic structure of proxy data.

## Foundational Learning

- **Concept: Zero-Shot Learning (ZSL) via Attribute Transfer**
  - Why needed here: Unlike standard transfer learning, ZSL relies on semantic or visual similarity to a known class to infer properties of an unknown class. Understanding that the model never "sees" the target label during training is crucial.
  - Quick check question: Does the model require any labeled examples of the target disease (Mild DR) during clustering phase? (Answer: No, it uses DM data).

- **Concept: Contrastive Loss in Siamese Networks**
  - Why needed here: The mechanism for finding the "proxy" disease depends on minimizing distance between similar images and maximizing it between dissimilar ones up to a margin.
  - Quick check question: In the loss function $L = \frac{1}{2}Y(D^2) + \frac{1}{2}(1-Y)(max(0, m-D))^2$, what happens if the margin $m$ is set too small? (Answer: The model may fail to distinguish distinct diseases, leading to poor proxy selection).

- **Concept: Hierarchical Clustering (Agglomerative)**
  - Why needed here: The final classification is unsupervised. Engineers must understand that AGG is "bottom-up" (merging points into clusters) and sensitive to the linkage criterion (ward, average, complete).
  - Quick check question: Why would AGG outperform KMeans in a medical context? (Answer: Medical data clusters are often non-spherical or elongated due to disease progression variances).

## Architecture Onboarding

- **Component map:** Input -> Siamese VGG19 -> U-Net ResNet50 -> ResNet18 -> Agglomerative Clustering -> Output
- **Critical path:** The Proxy Selector determines data quality; the Feature Filter (U-Net) determines signal clarity; the Classifier determines decision boundary. If Proxy Selector picks poor surrogate, subsequent steps cannot recover performance.
- **Design tradeoffs:** Generalization vs. Specificity (general features to diagnose specific target allows generalization but risks misdiagnosis); Complexity vs. Interpretability (pipeline uses three deep models, effective but poor interpretability).
- **Failure signatures:** Random Guessing (~0.50 Acc) likely failure in Siamese network to find relevant proxy; High Recall / Low Precision (ResNeXt backbone showed 0.92 Recall / 0.68 Prec) indicates cluster boundary encompasses too much noise; Catastrophic Drop (Acc < 0.35) observed in ablation when Segmentation removed indicates raw image signal insufficient.
- **First 3 experiments:**
  1. Sanity Check Proxy Quality: Before full pipeline, visualize t-SNE plot of Target Disease clinical features vs Top-3 similar diseases identified by Siamese network to confirm visual overlap.
  2. Segmentation Ablation: Run clustering algorithm on raw images vs U-Net masked images for known disease to quantify Signal-to-Noise ratio improvement provided by U-Net.
  3. Clustering Sensitivity Analysis: Test AGG linkage types ('ward' vs 'average') on ResNet embeddings to see how cluster hierarchy changes with different distance metrics.

## Open Questions the Paper Calls Out

### Open Question 1
Can the RURA-Net architecture be effectively adapted to handle multi-modal medical data (e.g., combining CFP with OCT or clinical demographics) while maintaining its zero-shot diagnostic capabilities? The conclusion explicitly identifies the limitation that the model is "currently only applicable to single-modality image data" and lists developing ZSL models for multiple imaging modalities as a primary direction for future work.

### Open Question 2
How can the "black box" nature of the ResNet-Agglomerative clustering and Siamese similarity components be improved to provide clinically interpretable explanations for diagnostic decisions? The authors acknowledge in the conclusion that the model has "poor interpretability," identifying it as a common limitation of deep learning-based diagnostic models that needs to be addressed.

### Open Question 3
Does the requirement for pixel-level lesion annotations to train the U-Net component undermine the method's utility for "Zero-Shot" scenarios where target disease data is truly scarce? While the paper claims to achieve Zero-Shot Learning, the methodology explicitly trains the U-Net segmentation model on datasets containing labeled lesions of the target disease (DR1), suggesting the method requires high-quality labeled data of the target's features.

## Limitations
- Proprietary LCFP-14M dataset (13.7 million images) is not publicly available, making independent validation difficult
- Method relies heavily on quality of proxy disease selection - incorrect identification of visually similar but clinically distinct disease causes complete pipeline failure
- Approach's generalizability to non-ophthalmic domains remains unproven, as does performance on diseases without well-defined, segmentable lesions
- Requires pixel-level lesion annotations, which may undermine true "Zero-Shot" utility when target disease data is truly scarce

## Confidence
- **High Confidence:** Ablation study demonstrating necessity of U-Net segmentation (accuracy drops from 0.8395 to 0.3074 without it)
- **Medium Confidence:** Claimed superiority over Few-Shot and One-Shot baselines (exact experimental setup not fully detailed)
- **Low Confidence:** Clinical interpretation that "Mild Diabetic Retinopathy" is accurately diagnosed when using "Degenerative Myopia" as proxy (assumes sufficient pathological feature overlap)

## Next Checks
1. Generate t-SNE visualizations comparing target disease clinical features against top-3 similar diseases identified by Siamese network to visually confirm pathological overlap before proceeding with full pipeline.
2. For a known disease (not Zero-Shot), measure change in clustering accuracy when using raw images versus U-Net segmented images to quantify actual Signal-to-Noise ratio improvement provided by segmentation.
3. Systematically test different Agglomerative Clustering linkage criteria ('ward', 'average', 'complete') on ResNet embeddings to determine how choice of distance metric affects final disease classification boundaries.